Bayer's Adalat XL product and Mylan's nifedipine extended release 60 mg not bioequivalent: Study

Links shared publicly online about this topic.

1,143
total visits

Bayer's Adalat XL product and Mylan's nifedipine extended release 60 mg not bioequivalent: Study

Bayer Inc. today responded to Professor Marvin Meyer's letter to the editor, entitled: "Critical questions concerning the validity of the Bayer study report of differences in bioavailability between 60 mg of nifedipine osmotic push-pull systems after fasted and fed administration" and published in the online edition of the International Journal of Clinical Pharmacology and Therapeutics. Bayer responded to the clinical relevance of the differences in formulation and dissolution behaviou

View full resource at news-medical.net

Tags: High Blood Pressure Medication, Pregnancy, Calcium Channel Blocker, Adalat, Procardia, Bayer

Most Recently Shared on May 25, 2010 at 9:17 am By:

News-Medical.Net

Pregnancy News: Bayer's Adalat XL product and Mylan's nifedipine extended release 60 mg not bioequivalent: Study: ... http://bit.ly/9EHoZy

2 years ago...

Retweet

Favorite

Study: Generic nifedipine product not bioequivalent to Adalat XL

news-medical.net — “An extended release generic nifedipine product (Mylan-Nifedipine extended release 60 mg formerly Gen-Nifedipine extended release 60mg, Genpharm ULC) is not bioequivalent to the Canadian originator product, Adalat(R) XL(R), according to the results of a study recently published in the International Journal of Clinical Pharmacology and Therapeutics.” View full resource at news-medical.net